Literature DB >> 16676931

Treatment of posttraumatic syringomyelia with extradural decompressive surgery.

L T Holly1, J P Johnson, J E Masciopinto, U Batzdorf.   

Abstract

The authors review the management of five patients with posttraumatic syringomyelia (PTS) associated with an uncorrected spinal deformity. Patients with evidence of progressive neurological deterioration underwent ventral spinal decompressive surgery. The mean patient age at the time of injury was 39 years, and the time between injury and the diagnosis of PTS ranged from 2 to 22 years. Mechanisms of injury consisted of fracture/subluxations in three patients and burst fractures in two. All patients experienced delayed neurological deterioration consistent with PTS. Magnetic resonance imaging revealed ventral deformities, and the spinal canal stenosis ranged from 20 to 50% (mean 39%). All patients underwent ventral epidural spinal decompressive surgery to correct the bone deformity and restore the spinal canal. The mean follow-up period was 38 months. The decompressive intervention was initially successful in treating the neurological deterioration in all patients. Symptoms resolved completely in four patients, and the other experienced neurological improvement. Postoperative magnetic resonance imaging revealed a reduction in the size of syrinx cavity in the patients whose symptoms resolved and no change in the remaining patient. Two patients required a subsequent second-stage posterior intradural exploration and duraplasty for recurrence of symptoms and/or syrinx. Posttraumatic spinal deformity may cause spinal canal stenosis and alter subarachnoid cerebrospinal fluid (CSF) flow in certain patients. Ventral epidural spinal decompressive surgery may result in neurological improvement and a reduction of the syrinx cavity, avoiding the need for placement of a shunt or other intradural procedures. However, some patients will also require reconstruction of the posterior subarachnoid space with duraplasty if the ventral decompressive procedure achieves only partial restoration of the subarachnoid CSF flow.

Entities:  

Mesh:

Year:  2000        PMID: 16676931     DOI: 10.3171/foc.2000.8.3.8

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  8 in total

1.  Management of acute traumatic spinal cord injury.

Authors:  Ryan A Grant; Jennifer L Quon; Khalid M Abbed
Journal:  Curr Treat Options Neurol       Date:  2015-02       Impact factor: 3.598

2.  Spinal cord untethering and midline myelotomy for delayed, symptomatic post-traumatic syringomyelia due to retained ballistic fragments: case report.

Authors:  Tej D Azad; Joshua Materi; Brian Y Hwang; Dimitrios Mathios; Kurt R Lehner; Landon Hansen; Lydia J Bernhardt; Yuanxuan Xia; Pavan P Shah; Nivedha V Kannapadi; Nicholas Theodore
Journal:  Spinal Cord Ser Cases       Date:  2022-07-12

Review 3.  [Correction of post-traumatic and congenital kyphosis: indications, techniques, results].

Authors:  D Stoltze; J Harms; B Boyaci
Journal:  Orthopade       Date:  2008-04       Impact factor: 1.087

4.  Post-traumatic syringomyelia.

Authors:  Amit Agrawal; M Shantharam Shetty; Lekha Pandit; Lathika Shetty; U Srikrishna
Journal:  Indian J Orthop       Date:  2007-10       Impact factor: 1.251

5.  A unifying hypothesis for hydrocephalus, Chiari malformation, syringomyelia, anencephaly and spina bifida.

Authors:  Helen Williams
Journal:  Cerebrospinal Fluid Res       Date:  2008-04-11

6.  Syringosubarachnoid shunting using a myringotomy tube.

Authors:  Jack M Leschke; Michael L Mumert; Shekar N Kurpad
Journal:  Surg Neurol Int       Date:  2016-01-07

7.  Treatment of posttraumatic syringomyelia: evidence from a systematic review.

Authors:  Andrea Kleindienst; Francisco Marin Laut; Verena Roeckelein; Michael Buchfelder; Frank Dodoo-Schittko
Journal:  Acta Neurochir (Wien)       Date:  2020-08-20       Impact factor: 2.216

8.  Syringo-peritoneal Shunt for Syringomyelia Due to Extensive Adhesive Arachnoiditis: A Case Report.

Authors:  Kyohei Kin; Takao Yasuhara; Atsuhiko Toyoshima; Isao Date
Journal:  NMC Case Rep J       Date:  2021-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.